Stem Cell Research

Scope & Guideline

Exploring the potential of regenerative medicine.

Introduction

Explore the comprehensive scope of Stem Cell Research through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Stem Cell Research in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1873-5061
PublisherELSEVIER
Support Open AccessYes
CountryNetherlands
TypeJournal
Convergefrom 2007 to 2024
AbbreviationSTEM CELL RES / Stem Cell Res.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Stem Cell Research' focuses on advancing scientific knowledge in the field of stem cell biology, emphasizing the generation and application of induced pluripotent stem cells (iPSCs) and their use in modeling diseases, regenerative medicine, and therapeutic development.
  1. Induced Pluripotent Stem Cells (iPSCs) Generation:
    The core focus of the journal is the generation of iPSC lines from various sources, including patients with specific genetic disorders, healthy donors, and other model organisms. This includes the application of advanced techniques such as CRISPR/Cas9 for gene editing.
  2. Disease Modeling:
    The journal frequently publishes research on the use of iPSCs to model a wide array of diseases, including neurodegenerative disorders, cardiac conditions, metabolic diseases, and genetic syndromes, providing insights into disease mechanisms and potential treatments.
  3. Therapeutic Applications:
    Research articles often explore the therapeutic implications of iPSCs, including their differentiation into specific cell types for transplantation and their use in drug screening and development.
  4. Ethnic and Genetic Diversity in Stem Cell Research:
    The journal highlights the importance of genetic diversity by publishing studies that include iPSC lines derived from diverse ethnic backgrounds and genetic profiles, aiming to enhance the applicability of stem cell therapies across different populations.
  5. Technological Innovations:
    Innovations in stem cell technologies, such as non-integrative reprogramming methods, advanced gene editing techniques, and the development of novel reporter lines for tracking differentiation and function, are also emphasized.
The journal 'Stem Cell Research' has demonstrated a dynamic evolution in its focus, with several emerging themes gaining traction. These trends reflect the ongoing advancements in stem cell technologies and their applications in various fields.
  1. CRISPR/Cas9 and Gene Editing:
    The use of CRISPR/Cas9 technology for gene editing in iPSCs is a rapidly growing area, with numerous studies focusing on creating specific gene knockouts or corrections to model diseases more accurately and develop potential therapies.
  2. Personalized Medicine and Patient-Derived iPSCs:
    There is a significant increase in research dedicated to generating patient-specific iPSCs for personalized medicine applications, particularly for diseases like Alzheimer's, Parkinson's, and various genetic disorders.
  3. Applications in Regenerative Medicine:
    Research that explores the application of iPSCs in regenerative medicine, including tissue engineering and organoid development, is on the rise, highlighting the potential for using iPSCs in clinical therapies.
  4. Mental Health and Neurological Disorders:
    The journal has seen an increase in studies focusing on the use of iPSCs to model mental health disorders, such as schizophrenia and autism, reflecting a growing interest in understanding the neurological basis of these conditions.
  5. Ethnic Diversity in Stem Cell Research:
    Emerging themes include the generation of iPSC lines from diverse ethnic groups to address health disparities and improve the applicability of stem cell therapies across different populations.

Declining or Waning

While 'Stem Cell Research' covers a broad spectrum of topics, certain areas have shown signs of declining interest or publication frequency over recent years. These waning scopes may reflect shifts in research priorities or advancements in technology that have rendered certain approaches less relevant.
  1. Adult Stem Cell Research:
    There has been a notable decrease in publications focusing solely on adult stem cells compared to iPSCs. This shift indicates a greater emphasis on iPSCs due to their versatility and the ability to generate patient-specific cell lines.
  2. Basic Stem Cell Biology:
    Research centered around the fundamental biology of stem cells, such as stem cell niche interactions and basic pluripotency mechanisms, appears to be waning as the field moves toward more applied research in disease modeling and therapy.
  3. Non-human Stem Cell Models:
    There has been a decline in papers utilizing non-human stem cell models (e.g., mouse or primate models) in favor of human-derived iPSCs, reflecting a trend towards research that is more directly applicable to human health.
  4. Stem Cell Banking and Ethics:
    Discussions and publications related to stem cell banking practices and the ethical implications of stem cell research have become less prominent, possibly due to the increasing normalization of iPSC research and clinical applications.

Similar Journals

American Journal of Stem Cells

Innovative insights shaping the future of biochemistry and genetics.
Publisher: E-CENTURY PUBLISHING CORPISSN: 2160-4150Frequency: 1 issue/year

American Journal of Stem Cells is a leading multidisciplinary publication dedicated to advancing the field of regenerative medicine and stem cell research. Published by E-CENTURY PUBLISHING CORP, this journal has gained recognition for its commitment to high-quality scientific contributions, achieving impressive rankings within the Scopus database, particularly in the areas of Biochemistry, Genetics and Molecular Biology, and Developmental Biology. With its focus on innovative research, the journal offers crucial insights and developments that appeal to researchers, professionals, and students alike. Although it is not an open-access journal, the American Journal of Stem Cells plays a pivotal role in disseminating impactful findings that define the future of cellular therapies and regenerative methodologies. The journal's past coverage from 2012 to 2017 reflects its dedication to advancing knowledge in key scientific disciplines, making it an essential resource for anyone engaged in the dynamic landscape of stem cell science.

CELLULAR & MOLECULAR BIOLOGY LETTERS

Transforming Knowledge in Biochemistry and Cell Biology
Publisher: BMCISSN: 1425-8153Frequency: 1 issue/year

CELLULAR & MOLECULAR BIOLOGY LETTERS, published by BMC, is a premier open-access journal dedicated to disseminating high-quality research in the fields of Biochemistry, Cell Biology, and Molecular Biology. Established in 1996, the journal has emerged as a leader in its domain, boasting an impressive Q1 ranking across three critical categories as of 2023, reflecting its significant impact within the scientific community. With an ISSN of 1425-8153 and an E-ISSN of 1689-1392, it offers accessible research findings to a global audience, having been open access since 2013. Situated in the United Kingdom, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, the journal continues to serve as a vital resource for researchers, professionals, and students, contributing to advancements in the understanding of cellular and molecular processes. By providing a platform for original research, reviews, and short communications, CELLULAR & MOLECULAR BIOLOGY LETTERS plays a crucial role in fostering dialogue and collaboration within the scientific community.

STEM CELLS AND DEVELOPMENT

Advancing the Frontiers of Stem Cell Research
Publisher: MARY ANN LIEBERT, INCISSN: 1547-3287Frequency: 24 issues/year

STEM CELLS AND DEVELOPMENT, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the rapidly advancing fields of stem cell biology and developmental science. With an ISSN of 1547-3287 and an E-ISSN of 1557-8534, the journal encompasses a broad range of topics central to understanding stem cells' roles in development and regeneration processes. It holds a prestigious standing within its category quartiles, ranking Q3 in Cell Biology, Q2 in Developmental Biology, and Q2 in Hematology for 2023. With its convergence from 2004 to 2024, STEM CELLS AND DEVELOPMENT fosters an innovative platform for researchers, professionals, and students to disseminate groundbreaking research, share insights, and explore novel therapeutic approaches. Open access options enhance the journal's visibility and accessibility, promoting a collaborative exchange of information among the scientific community. Positioned at the forefront of stem cell research and its applications, this journal is vital for anyone seeking to stay informed about the latest advancements and trends within these critical areas of study.

Current Stem Cell Reports

Advancing the Frontiers of Stem Cell Science
Publisher: SPRINGER HEIDELBERGISSN: Frequency: 4 issues/year

Current Stem Cell Reports, published by Springer Heidelberg, is an esteemed academic journal that has emerged as a pivotal resource in the fields of Cell Biology, Developmental Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has consistently contributed to the evolving discourse on stem cell research and its applications, providing a platform for innovative studies and reviews through 2024. With a notable impact indicated by its quartile rankings—Q2 in Developmental Biology and Genetics, and Q3 in Cell Biology and Molecular Biology—it engages a diverse audience of researchers, professionals, and students who seek high-quality, accessible research insights. Although offering a traditional access model, the content remains vital for those invested in understanding the implications of stem cell advancements. Located in Switzerland and operating from the heart of Heidelberg, this journal aspires to bridge gaps in knowledge and stimulate collaboration in the burgeoning field of stem cell science.

Stem Cells International

Advancing the Frontiers of Stem Cell Research
Publisher: HINDAWI LTDISSN: 1687-966XFrequency:

Stem Cells International is a premier open access journal published by HINDAWI LTD, focusing on the rapidly evolving field of stem cell research. With an ISSN of 1687-966X and E-ISSN 1687-9678, this journal has been a vital resource since its inception in 2010, showcasing innovative studies and breakthroughs up to 2024. Positioned in Q3 in Cell Biology and Q2 in Molecular Biology for 2023, as well as well-ranked in the Scopus database, the journal serves as an essential platform for researchers, professionals, and students dedicated to exploring the implications of stem cell technology in regenerative medicine and biological research. The open access model ensures wide accessibility, fostering collaboration and knowledge-sharing across the scientific community, making it a cornerstone in advancing the understanding and application of stem cell science.

DIFFERENTIATION

Exploring the Complexities of Life's Building Blocks
Publisher: ELSEVIER SCI LTDISSN: 0301-4681Frequency: 6 issues/year

DIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.

Russian Journal of Developmental Biology

Diving deep into the dynamics of development.
Publisher: PLEIADES PUBLISHING INCISSN: 1062-3604Frequency: 6 issues/year

The Russian Journal of Developmental Biology, published by PLEIADES PUBLISHING INC, serves as a significant platform for researchers and professionals engaged in the field of developmental biology. With the ISSN 1062-3604 and E-ISSN 1608-3326, this journal focused on intricate biological processes and dynamic developmental mechanisms from 2005 until 2017. Although its coverage is currently discontinued in Scopus, it remains notable for its contribution to understanding the pivotal roles of biochemistry and molecular genetics within the context of development. As a publication situated in the competitive quartiles of the field and boasting an influential Scopus rank of #77 out of #78, it has made a unique mark in developmental studies. Researchers and academics seeking to enhance their knowledge of historical advancements in the discipline will find the journal a valuable resource, even as it navigates the transition away from active publication.

Cellular Reprogramming

Pioneering Research in Cellular Reprogramming
Publisher: MARY ANN LIEBERT, INCISSN: 2152-4971Frequency: 6 issues/year

Cellular Reprogramming is a prominent academic journal published by MARY ANN LIEBERT, INC, dedicated to advancing the field of cellular biology and biotechnology. With its ISSN 2152-4971 and E-ISSN 2152-4998, this journal provides an innovative platform for researchers and professionals to share groundbreaking research findings on cellular reprogramming, stem cell biology, and regenerative medicine. Established in 2010, and actively publishing until 2024, the journal is recognized for its contributions, evidenced by its categorizations in the Q3 and Q4 quartiles across several related fields, including biotechnology and developmental biology. This peer-reviewed journal not only supports open access to scientific literature but also aims to enhance interdisciplinary collaboration among scientists. With a growing impact in the realms of biochemistry, genetics, and molecular biology, Cellular Reprogramming remains an essential resource for the dissemination of pioneering research that could shape the future of cellular therapies.

Stem Cell Research & Therapy

Advancing the Frontiers of Regenerative Medicine
Publisher: BMCISSN: Frequency: 1 issue/year

Stem Cell Research & Therapy is an esteemed international journal published by BMC, specializing in the rapidly advancing fields of stem cell research and regenerative therapies. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that vital research is readily accessible to a global audience. With a significant impact in the scientific community, it holds Q1 quartile rankings in prestigious categories such as Biochemistry, Genetics and Molecular Biology, Cell Biology, and Molecular Medicine, highlighting its critical role in promoting groundbreaking research. The journal’s high Scopus rankings—placing it in the top echelons of its fields—reflect its commitment to publishing high-quality, peer-reviewed studies that advance our understanding of stem cell biology and therapeutic applications. Aimed at researchers, healthcare professionals, and students alike, Stem Cell Research & Therapy is an indispensable resource for those dedicated to the exploration and innovation within this transformative area of science.

Stem Cells and Cloning-Advances and Applications

Innovating Solutions through Stem Cell Research
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6957Frequency: 1 issue/year

Stem Cells and Cloning-Advances and Applications is a leading peer-reviewed journal dedicated to the dynamic fields of stem cell research and cloning technologies. Published by DOVE MEDICAL PRESS LTD in New Zealand since 2008, this Open Access journal ensures that groundbreaking findings are accessible to a global audience. With a focus on innovative applications and advancements in cellular biology, the journal plays a pivotal role in disseminating knowledge within the scientific community. The journal currently holds an impact factor that reflects its influence, with notable rankings in both Cell Biology and Medicine (Miscellaneous), showcasing its interdisciplinary relevance. Researchers, professionals, and students alike benefit from the journal’s wide-ranging contributions, covering critical topics from regenerative medicine to genetic research. With a commitment to fostering collaboration and encouraging discussion in these cutting-edge domains, Stem Cells and Cloning-Advances and Applications continues to be a vital resource for advancing scientific inquiry and application.